Our Heart Failure Therapy Solution

First-In-Human Study

First-In-Human Study is showing significant improvements from the start (7 patients as of Oct 2019, more to follow)

The first in human pilot study has been designed as an open non-randomized study. Ten patients with pronounced non-ischemic dilated cardiomyopathy were included and treated with a C-MIC system. The study will be completed in April 2020 (last patient out). First results showing overwhelming effects of microcurrent application. Details will be published in a scientific journal in the very near future after completion of the study.

Back to overview